TY - JOUR
T1 - Relationship Between Breast Density, Breast Cancer Subtypes, and Prognosis
AU - Yamada, Daisuke
AU - Ohde, Sachiko
AU - Kajiura, Yuka
AU - Yagishita, Kazuyo
AU - Nozaki, Fumi
AU - Suzuki, Koyu
AU - Kanomata, Naoki
AU - Yamauchi, Hideko
AU - Tsunoda, Hiroko
N1 - Publisher Copyright:
© 2022 Elsevier Inc.
PY - 2022/8
Y1 - 2022/8
N2 - Background: In the United States, Europe, and Asia, a consensus has been reached that there is a higher risk of breast cancer in high density breasts. However, there are some contrary reports that suggest the absence of an association between breast composition and breast cancer subtype; thus, there is conflicting evidence. The purpose of this study was to investigate trends in the incidence of breast cancer subtypes according to breast composition and analyze the survival rates in Japanese women. Patients and Methods: Between 2007 and 2008, 1258 Japanese patients with invasive breast cancer who underwent mammography and obtained a pathological diagnosis in our institution were included in the study. We compared cancer subtypes with breast composition types (dense and non-dense breast), and classified them based on initial mammography findings. Information on 5- and 10-year survival rates was collected by chart review for patients with dense and nondense breasts. Statistical analysis was performed using the Pearson's chi-square test for breast composition and cancer subtype. The effect of breast composition on mortality was examined using a multivariate Cox proportional hazards model, and adjusted hazard ratios were calculated. Results: No significant difference was found between breast cancer subtype and breast composition (P = .08). Five-year (log-rank test, P = .09) and 10-year (log-rank test, P = .31) survival rates were not significantly different between breast composition types. Conclusion: There was no significant association between breast composition and cancer subtypes. There was also no significant difference in the prognosis between patients with and without dense breasts.
AB - Background: In the United States, Europe, and Asia, a consensus has been reached that there is a higher risk of breast cancer in high density breasts. However, there are some contrary reports that suggest the absence of an association between breast composition and breast cancer subtype; thus, there is conflicting evidence. The purpose of this study was to investigate trends in the incidence of breast cancer subtypes according to breast composition and analyze the survival rates in Japanese women. Patients and Methods: Between 2007 and 2008, 1258 Japanese patients with invasive breast cancer who underwent mammography and obtained a pathological diagnosis in our institution were included in the study. We compared cancer subtypes with breast composition types (dense and non-dense breast), and classified them based on initial mammography findings. Information on 5- and 10-year survival rates was collected by chart review for patients with dense and nondense breasts. Statistical analysis was performed using the Pearson's chi-square test for breast composition and cancer subtype. The effect of breast composition on mortality was examined using a multivariate Cox proportional hazards model, and adjusted hazard ratios were calculated. Results: No significant difference was found between breast cancer subtype and breast composition (P = .08). Five-year (log-rank test, P = .09) and 10-year (log-rank test, P = .31) survival rates were not significantly different between breast composition types. Conclusion: There was no significant association between breast composition and cancer subtypes. There was also no significant difference in the prognosis between patients with and without dense breasts.
KW - Breast cancer
KW - Breast density
KW - Dense breast
KW - Mammography
KW - Survival rate
UR - http://www.scopus.com/inward/record.url?scp=85130353531&partnerID=8YFLogxK
U2 - 10.1016/j.clbc.2022.04.005
DO - 10.1016/j.clbc.2022.04.005
M3 - Article
C2 - 35581133
AN - SCOPUS:85130353531
SN - 1526-8209
VL - 22
SP - 560
EP - 566
JO - Clinical Breast Cancer
JF - Clinical Breast Cancer
IS - 6
ER -